Key Product Details
Description: | Selective inhibitor of TGF-βRI |
Chemical Name: | 6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline |
Purity: | ≥97% (HPLC) |
Molecular Weight: | 343.42 |
Customers also Viewed
Customers also Purchased
Citations for SB 525334 (7)
Citations are publications that use Bio-Techne products. Selected citations for SB 525334 include:
-
Kilari et al.
(2018)
Increased transforming growth factor beta (TGF-β) and pSMAD3 signaling in a Murine Model for Contrast Induced Kidney Injury.
Sci Rep.
8:6630
PMID: 29700311 -
Kleczko et al.
(2015)
An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases.
PLoS One.
10:e0123600
PMID: 25946135 -
Gutiérrez et al.
(2015)
RECK-Mediated β1-Integrin Regulation by TGF-β1 Is Critical for Wound Contraction in Mice.
Lab Chip.
10:e0135005
PMID: 26247610 -
Grygielewicz et al.
(2014)
Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells.
Gastric Cancer.
2014;
PMID: 25407459 -
Denby et al.
(2014)
MicroRNA-214 antagonism protects against renal fibrosis.
J Am Soc Nephrol.
25:65
PMID: 24158985 -
Li et al.
(2013)
Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments.
Sci Rep.
13:1969
PMID: 23563587 -
Ng et al.
(2012)
Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
Clin Cancer Res.
18:4122
PMID: 22675171
There are no citations that match your criteria.